Related content

A pharmacokinetic and pharmacodynamic study In vivo of human HT29 tumours using 19 F and 31 P magnetic resonance spectroscopy

By McSheehy P.M.J.   Seymour M.T.   Ojugo A.S.E.   Rodrigues L.M.   Leach M.O.   Judson I.R.   Griffiths J.R.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2418-2427

Elsevier

Access to resources Recommend Favorite

Ex vivo 1H and 31P magnetic resonance spectroscopy as a means for tumor characterization in ovarian cancer patients

By        

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 321-328

Spandidos Publications

Access to resources Recommend Favorite

Heat-induced changes in intracellular Na + , pH and bioenergetic status in superfused RIF-1 tumour cells determined by 23 Na and 31 P magnetic resonance spectroscopy

By Babsky A.   Hekmatyar S. K.   Gorski T.   Nelson D. S.   Bansal N.  

International Journal of Hyperthermia, Vol. 21, Iss. 2, 2005-03 ,pp. : 141-158

Informa Healthcare

Access to resources Recommend Favorite

Clinical utility of proton magnetic resonance spectroscopy in the diagnosis of breast tumors

By Miao Yanwei  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 326-331

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: ^{31}P and ^{13}C nuclear magnetic resonance studies

By Vivi A.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 15-25

Springer Publishing Company

Access to resources Recommend Favorite